SFB Q1 2026 Earnings Modest EPS Beat Amid Stable Performance Safe Bulkers Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Phase Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment MVIS Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Stock Rises IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque